Gilead life sciences- An American Biopharmaceutical company has announced results of phase 3 trial of an antiviral drug called Remdesivir.. the results found effective...
Earlier USFDA had given an interim Approval based on phase 1/ 2 trial...
It appears until a vaccination is developed, Remdesivir can serve as an interim solution.
gilead.com/news-and-press/p...